èŠ‚ç‚¹æ–‡çŒ®

ä¸å›½éª¨éª¼è‚Œè¡°è€æ ‡å¿—ç‰©ä¸“å®¶å…±è¯†ï¼ˆ2024ï¼‰è®¡åˆ’ä¹¦

Chinese expert consensus on skeletal muscle aging biomarkers (2024): a protocol

æŽ¨è CAJä¸‹è½½
PDFä¸‹è½½
ä¸æ”¯æŒè¿…é›·ç‰ä¸‹è½½å·¥å…·ï¼Œè¯·å–æ¶ˆåŠ é€Ÿå·¥å…·åŽä¸‹è½½ã€‚

ã€ä½œè€…ã€‘ æŽä»£èï¼› é»„å®ï¼› è‘›ç¾ŽçŽ²ï¼› åˆ˜æ™“è•¾ï¼› å¼ å‹‡ï¼› ç”°æ—ï¼› å°¹é¹æ»¨ï¼› åˆ˜å‹‡ï¼› æ¨é’ŸåŠ›ï¼› å²³å†€è“‰ï¼› è‘£ç¢§è“‰ï¼›

ã€Authorã€‘ LI Daiping;HUANG Ning;GE Meiling;LIU Xiaolei;ZHANG Yong;TIAN Xu;YIN Pengbin;LIU Yong;YANG Zhongli;YUE Jirong;DONG Birong;Department of Geriatrics and National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University;State Key Laboratory for Complex, Severe, and Rare Diseases, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College;Guangzhou Bioland Laboratory;Senior Department of Orthopedics, the Fourth Medical Center of PLA General Hospital, National Clinical Research Center for Orthopedics,Sports Medicine & Rehabilitation;College of Life Sciences, Wuhan University;

ã€é€šè®¯ä½œè€…ã€‘ å²³å†€è“‰;è‘£ç¢§è“‰;

ã€æœºæž„ã€‘ å›½å®¶è€å¹´ç–¾ç—…ä¸´åºŠåŒ»å¦ç ”ç©¶ä¸å¿ƒ/å››å·å¤§å¦åŽè¥¿åŒ»é™¢è€å¹´åŒ»å¦ä¸å¿ƒï¼› ç–‘éš¾é‡ç—‡åŠç½•è§ç—…å…¨å›½é‡ç‚¹å®žéªŒå®¤,ä¸å›½åŒ»å¦ç§‘å¦é™¢åŸºç¡€åŒ»å¦ç ”ç©¶æ‰€,åŒ—äº¬åå’ŒåŒ»å¦é™¢åŸºç¡€å¦é™¢ï¼› å¹¿å·žç”Ÿç‰©å²›å®žéªŒå®¤ï¼› è§£æ”¾å†›æ€»åŒ»é™¢ç¬¬å››åŒ»å¦ä¸å¿ƒéª¨ç§‘åŒ»å¦éƒ¨,å›½å®¶éª¨ç§‘ä¸Žè¿åŠ¨åº·å¤ä¸´åºŠåŒ»å¦ç ”ç©¶ä¸å¿ƒï¼› æ¦æ±‰å¤§å¦ç”Ÿå‘½ç§‘å¦å¦é™¢ï¼›

ã€æ‘˜è¦ã€‘ éšç€æˆ‘å›½äººå£è€é¾„åŒ–çš„ä¸æ–åŠ å‰§ï¼Œè€å¹´äººç¾¤çš„éª¨éª¼è‚Œè¡°è€ä¸¥é‡å½±å“å›½æ°‘å¥åº·å¹¶å¯¹å…¬å…±å«ç”Ÿä½“ç³»æž„æˆä¸¥å³»æŒ‘æˆ˜ã€‚åŠæ—©å‘çŽ°éª¨éª¼è‚Œè¡°è€ï¼ŒåŠæ—©é¢„è¦ã€é¢„é˜²å’Œæ²»ç–—éª¨éª¼è‚Œè¡°è€ï¼Œå¯¹å®žçŽ°å¥åº·è€é¾„åŒ–å…·æœ‰é‡è¦æ„ä¹‰ã€‚ä¸ºç›é€‰å‡ºä¸€ç³»åˆ—å…·æœ‰ä¸´åºŠå¯æ“ä½œæ€§éª¨éª¼è‚Œè¡°è€ç”Ÿç‰©æ ‡å¿—ç‰©ï¼Œè¿›ä¸€æ¥è§„èŒƒéª¨éª¼è‚Œè¡°è€çš„æ—©æœŸè¯†åˆ«å’Œç²¾å‡†è¯Šæ–ï¼Œå¤šå¦ç§‘å›¢é˜Ÿæ³¨å†Œå¹¶æ’°å†™äº†æœ¬ä¸“å®¶å…±è¯†è®¡åˆ’ä¹¦ï¼Œä»¥æœŸè§„èŒƒå…±è¯†åˆ¶è®¢ï¼Œæé«˜å…±è¯†åˆ¶è®¢é€æ˜ŽåŒ–ã€‚æ›´å¤š è¿˜åŽŸ

ã€Abstractã€‘ With the continuous aging of the population in China, the aging of skeletal muscle in the elderly has seriously affected national health and poses a severe challenge to the public health system. Early detection of skeletal muscle aging, and early warning, prevention, and treatment are of great significance for achieving healthy aging. In order to select a series of clinically operable biomarkers for skeletal muscle aging, and to further standardize the early identification and precise diagnosis of skeletal muscle aging, a multidisciplinary team of experts has registered and written this protocol to provide a detailed introduction to the planning process for the development of the consensus.æ›´å¤š è¿˜åŽŸ